Cited by 289Obstructive Sleep Apnea ResearchHormonal Regulation and HypertensionApelin-related biomedical research

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

Open access

Gaddam, K, Pimenta, E, Thomas, S J, Cofield, S S, Oparil, S, Harding, S M, Calhoun, D A·2010·Journal of Human Hypertension

DOI 10.1038/jhh.2009.96PMC PMC2891919

Open this paper in CoChat — free account

Abstract

Obstructive sleep apnoea (OSA) and hyperaldosteronism are very common in subjects with resistant hypertension. We hypothesized that aldosterone-mediated chronic fluid retention may influence OSA severity in patients with resistant hypertension. We tested this in an open-label evaluation by assessing the changes in the severity of OSA in patients with resistant hypertension after treatment with spironolactone. Subjects with resistant hypertension (clinical blood pressure (BP) >or=140/90 mm Hg on >or=3 antihypertensive medications, including a thiazide diuretic and OSA (defined as an apnoea-hypopnoea index (AHI) >or=15) had full diagnostic, polysomnography before and 8 weeks after spironolactone (25-50 mg a day) was added to their ongoing antihypertensive therapy. In all, 12 patients (mean age 56 years and body mass index 36.8 kg m(-2)) were evaluated. After treatment with spironolactone, the AHI (39.8+/-19.5 vs 22.0+/-6.8 events/h; P<0.05) and hypoxic index (13.6+/-10.8 vs 6.7+/-6.6 events/h; P<0.05), weight and clinic and ambulatory BP were significantly reduced. Plasma renin activity (PRA) and serum creatinine were significantly higher. This study provides preliminary evidence that treatment with a mineralocorticoid receptor antagonist substantially reduces the severity of OSA. If confirmed in a randomized assessment, it will support aldosterone-mediated chronic fluid retention as an important mediator of OSA severity in patients with resistant hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/jhh.2009.96

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. R. (2016) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,285
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Self-citation
Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea
Schulz, R., MAHMOUDI, S., Hattar, K., Sibelius, U., Olschewski, H., Mayer, K., Seeger, W., & Grimminger, F. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9908091 · Cited by 639

Flagged first, then by citations

Show all 26 references

1 of the 26 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 289

Management of Hypertension in Obstructive Sleep Apnea
Furlan, S. F., Braz, C. V., Lorenzi‐Filho, G., & Drager, L. F. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0663-z · Cited by 33
Vascular changes, Cardiovascular Disease and Obstructive Sleep Apnea
Ramar, K., & Caples, S. M. (2011) · Future Cardiology · doi:10.2217/fca.10.123 · Cited by 33
Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives
Larik, F. A., Saeed, A., Shahzad, D., Faisal, M., El-Seedi, H. R., Mehfooz, H., & Channar, P. A. (2016) · Steroids · doi:10.1016/j.steroids.2016.12.010 · Cited by 33
The Association of Obstructive Sleep Apnea and Hypertension
Patel, A. R., Patel, A. R., Singh, S., Singh, S., & Khawaja, I. (2019) · Cureus · doi:10.7759/cureus.4858 · Cited by 35
The Egyptian Hypertension Society
(2014) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2014.03.001 · Cited by 33
Sleep disturbances: one of the culprits of obesity-related cardiovascular risk?
Muscogiuri, G., Tuccinardi, D., Nicastro, V., Barrea, L., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0019-z · Cited by 34
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA)
the Italian Society of Hypertension (SIIA), Pinto, R. D., SIIA Young Researchers Study Group, President of, S. I. I. A., Past President of, S. I. I. A., Italian Society of Hypertension (SIIA), Grassi, G. M., Ferri, C., Pengo, M. F., Lombardi, C., et al. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00436-y · Cited by 35
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
Epstein, M., & Duprez, D. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.01.039 · Cited by 31
Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea
Dobrowolski, P., Kołodziejczyk‐Kruk, S., Warchoł-Celińska, E., Kabat, M., Ambroziak, U., Wróbel, A., Piekarczyk, P., Ostrowska, A., Januszewicz, M., Śliwiński, P., et al. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8960 · Cited by 31
Renal Sympathetic Denervation
Egan, B. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179101 · Cited by 31
Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension
de Souza, F., Muxfeldt, E. S., Margallo, V. S., Cortez, A. F., Cavalcanti, A. H., & Salles, G. F. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001254 · Cited by 30
Berberine Improved Aldo-Induced Podocyte Injury via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress Pathways both In Vivo and In Vitro
Wang, B., Xu, X., He, X., Wang, Z., & Yang, M. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445618 · Cited by 29
Sympathetic nerves and hypertension in stress, sleep apnea, and caregiving
Ziegler, M. G., & Milic, M. S. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000288 · Cited by 31
Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
Pecori, A., Buffolo, F., Pieroni, J., Forestiero, V., Sconfienza, E., Veglio, F., Mulatero, P., & Monticone, S. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1133-7255 · Cited by 28
Cardiovascular regulation in obstructive sleep apnea
Ziegler, M. G., Milic, M. S., & Elayan, H. H. (2011) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2011.03.003 · Cited by 28
Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
Thomopoulos, C., Michalopoulou, H., Kasiakogias, A., Kefala, A., & Makris, T. K. (2011) · International Journal of Hypertension · doi:10.4061/2011/947246 · Cited by 28
The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension—A Randomized, Controlled Trial
Krasińska, B., Cofta, S., Szczepaniak‐Chicheł, L., Rzymski, P., Trafas, T., Paluszkiewicz, L., Tykarski, A., & Krasiński, Z. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101671 · Cited by 27
The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
Sato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26
Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea
Aishah, A., & Eckert, D. J. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000628 · Cited by 29
Impact of Sacubitril–Valsartan Combination in Patients with Chronic Heart Failure and Sleep Apnoea Syndrome: The ENTRESTO-SAS Study Design
Jaffuel, D., Molinari, N., Berdagué, P., Pathak, A., Galinier, M., Dupuis, M., Ricci, J., Mallet, J., BOURDIN, A. A., & Roubille, F. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12270 · Cited by 26
Role of sleep disorders in patients with cardiovascular disease: A systematic review
Zhang, L., Li, G., Bao, Y., & Liu, M. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200257 · Cited by 27
JCS 2023 Guideline on Diagnosis and Treatment of Sleep Disordered Breathing in Cardiovascular Disease
Kasai, T., Kohno, T., Shimizu, W., Ando, S., Joho, S., Osada, N., Kato, M., Kario, K., Shiina, K., Tamura, A., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0489 · Cited by 25
Effect of different treatments for obstructive sleep apnoea on blood pressure
Kou, C., Zhao, X., Lin, X., Fan, X., Wang, Q., & Yu, J. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003131 · Cited by 24
Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.
Jehan, S., Zizi, F., Pandi-Perumal, S. R., McFarlane, S. I., Jean‐Louis, G., & Myers, A. K. (2020) · PubMed · Cited by 24
Meta-Analysis of the Effect of Renal Denervation on Blood Pressure and Pulse Pressure in Patients With Resistant Systemic Hypertension
Pancholy, S. B., Shantha, G. P. S., Patel, T. M., Sobotka, P. A., & Kandzari, D. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.06.018 · Cited by 23
The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions
Diogo, L. N., & Monteiro, E. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00361 · Cited by 25
Who May Benefit From Diuretics in OSA?
Revol, B., Jullian‐Desayes, I., Bailly, S., Tamisier, R., Grillet, Y., Sapène, M., Joyeux‐Faure, M., Pépin, J., Grillet, Y., Sapène, M., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.050 · Cited by 23
Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Loh, H. H., & Sukor, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976979 · Cited by 23
Pharmacotherapy of obstructive sleep apnea
Lin, C. M., Huang, Y. S., & Guilleminault, C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.666525 · Cited by 23
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison
Wolley, M. J., & Stowasser, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0641-x · Cited by 24
Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice
Volpe, M., & Tocci, G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.47 · Cited by 22
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome
Valaiyapathi, B., & Calhoun, D. A. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0819-5 · Cited by 22
Self-citation
Drug Therapy in Obstructive Sleep Apnea
Hedner, J. A., & Zou, D. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.03.004 · Cited by 23
Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin–angiotensin–aldosterone system activity in humans with obstructive sleep apnea
Nicholl, D. D. M., Hanly, P. J., Zalucky, A. A., Handley, G. B., Sola, D. Y., & Ahmed, S. B. (2020) · SLEEP · doi:10.1093/sleep/zsaa228 · Cited by 24
Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
Glicklich, D., & Frishman, W. H. (2015) · Drugs · doi:10.1007/s40265-015-0372-3 · Cited by 21
The Demystification of Secondary Hypertension: Diagnostic Strategies and Treatment Algorithms
Hirsch, J. S., & Hong, S. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0790-8 · Cited by 21
Hypervolemia and Sleep Apnea in Kidney Disease
Lyons, O. D., Bradley, T. D., & Chan, C. T. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.06.008 · Cited by 20
Treating sleep disorders to improve blood pressure control and cardiovascular prevention: a dream come true?—a narrative review
Maiolino, G., Bisogni, V., Silvani, A., Pengo, M. F., Lombardi, C., & Parati, G. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-cus-2020-014 · Cited by 22
Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits
Perger, E., Bertoli, S., & Lombardi, C. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2241353 · Cited by 23
Effects of esaxerenone on blood pressure, urinary albumin excretion, serum levels of NT-proBNP, and quality of life in patients with primary aldosteronism
Yoshida, Y., Fujiwara, M., Kinoshita, M., Sada, K., Miyamoto, S., Ozeki, Y., Iwamoto, M., Mori, Y., Nagai, S., Matsuda, N., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01412-w · Cited by 20
Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management
Williams, S. K., Ravenell, J. E., Jean‐Louis, G., Zizi, F., Underberg, J. A., McFarlane, S. I., & Ogedegbe, G. G. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0161-z · Cited by 20
Resistant Hypertension: Diagnosis and Management
Nagarajan, N., & Jalal, D. I. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.03.002 · Cited by 21
Sleep-Disordered Breathing and Resistant Hypertension
Wang, A. Y.-M. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.006 · Cited by 21
Obstructive sleep apnea syndrome, continuous positive airway pressure and treatment of hypertension
Floras, J. S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.024 · Cited by 22
Non-Hypertensive Effects of Aldosterone
Ekman, N., Grossman, A. B., Nieckarz, A., Jędrzejewski, Ł., Wolf, J., & Dorota Dworakowska, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020540 · Cited by 19
Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension
Burnier, M., & Wuerzner, G. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.003 · Cited by 18
Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea
Chee, M. R., Hoo, J., Libianto, R., Gwini, S. M., Hamilton, G. S., Narayan, O. P., Young, M. J., Fuller, P. J., & Yang, J. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16902 · Cited by 18
Effects of heart failure and its pharmacological management on sleep
Jiménez, J. A., Greenberg, B., & Mills, P. J. (2011) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2011.02.006 · Cited by 19
Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?
Loh, H. H., & Sukor, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0294-8 · Cited by 19
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension
Ghazi, L., Oparil, S., Calhoun, D. A., Lin, C. P., & Dudenbostel, T. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08632 · Cited by 18
Self-citation
Turning Over a New Leaf—Pharmacologic Therapy in Obstructive Sleep Apnea
Hedner, J. A., & Zou, D. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.06.010 · Cited by 16
Sleep Disturbances and Resistant Hypertension: Association or Causality?
Pereira, D. C. G., Pedrosa, R. P., Lorenzi‐Filho, G., & Drager, L. F. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0459-3 · Cited by 16
Hyperaldosteronism: Screening and Diagnostic Tests
Sabbadin, C., & Fallo, F. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0136-5 · Cited by 16
Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial
Thunström, E. Ö., Manhem, K., Yucel‐Lindberg, T., Rosengren, A., Lindberg, C., & Peker, Y. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-126oc · Cited by 16
Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension
Morimoto, S., & Ichihara, A. (2020) · Hypertension Research · doi:10.1038/s41440-020-0468-3 · Cited by 16
Sleep-Disordered Breathing and Hypertension—A Systematic Review
Battisha, A., Kahlon, A., & Kalra, D. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093115 · Cited by 18
Resistant Hypertension
Townsend, R. R., & Epstein, M. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07316 · Cited by 15
Sex differences in renal hemodynamics and renin-angiotensin system activity post-CPAP therapy in humans with obstructive sleep apnea
Nicholl, D. D. M., Hanly, P. J., Zalucky, A. A., Handley, G. B., Sola, D. Y., & Ahmed, S. B. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00290.2019 · Cited by 15
Obstructive sleep apnoea, resistant hypertension and renal denervation
Witkowski, A., & Kądziela, J. (2013) · EuroIntervention · doi:10.4244/eijv9sra18 · Cited by 14
Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
Yoshida, Y., Yoshida, R., Shibuta, K., Ozeki, Y., Okamoto, M., Gotoh, K., Masaki, T., & Shibata, H. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab020 · Cited by 13
Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism
Yoshida, Y., & Shibata, H. (2024) · Hypertension Research · doi:10.1038/s41440-024-01970-7 · Cited by 13
Superior hypertension control with betablockade in the European Sleep Apnea Database
Svedmyr, S., Hedner, J. A., Zou, D., Parati, G., Ryan, S., Hein, H., Pépin, J., Tkáčová, R., Marrone, O., Schiza, S. E., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002629 · Cited by 13
Treatment Considerations With Aldosterone Receptor Antagonists
Sica, D. A., & Flack, J. M. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00377.x · Cited by 13
Effect of diuretics and sodium-restricted diet on sleep apnea severity: study protocol for a randomized controlled trial
Fiori, C. Z., Martinez, D., Gonçalves, S. C., Montanari, C. C., & Fuchs, F. D. (2015) · Trials · doi:10.1186/s13063-015-0699-9 · Cited by 13
Treatment Resistant Hypertension
Egan, B. M. (2015) · Ethnicity & Disease · doi:10.18865/ed.25.4.495 · Cited by 13
Cardiovascular Effects of Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Meta-Analysis
Aslan, G., Afşar, B., Siriopol, D. C., Kanbay, A., Sal, O., Benli, C., Okcuoglu, J., Covic, A. C., & Kanbay, M. (2017) · Angiology · doi:10.1177/0003319717709175 · Cited by 13
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea
Wang, E. Y., Chomsky‐Higgins, K. H., Chen, Y., Nwaogu, I. Y., Seib, C. D., Shen, W. T., Duh, Q., & Suh, I. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.10.040 · Cited by 13
Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea
Conroy, P. C., Hernandez, S., Graves, C. E., Menut, K. C., Pearlstein, S., Liu, C., Shen, W. T., Gosnell, J. E., Sosa, J. A., Roman, S. A., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.07.041 · Cited by 12
The pharmacotherapeutic management of obstructive sleep apnea
Marra, S., Arnaldi, D., & Nobili, L. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1652271 · Cited by 12
A Narrative Review of the Association of Obstructive Sleep Apnea with Hypertension: How to Treat Both When They Coexist?
Altay, S., Fırat, S., Peker, Y., & Collaborators, T. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124144 · Cited by 11
Breaking Ground: From CPAP Treatment to the First Medicine for OSA Patients with Obesity
Lisik, D., & Zou, D. (2025) · Current Pulmonology Reports · doi:10.1007/s13665-024-00365-w · Cited by 12
Blood pressure profile and nocturnal oxygen desaturation
Lattanzi, S., Brigo, F., & Silvestrini, M. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13259 · Cited by 11
Association of objective and subjective parameters of obstructive sleep apnea with plasma aldosterone concentration in 2,066 hypertensive and 25,368 general population
Wang, H., Heizhati, M., Li, N., Gan, L., Lin, M., Yang, W., Li, M., Yao, L., Liu, M., Maitituersun, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1016804 · Cited by 11
Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series
Wernze, H., & Herdegen, T. (2014) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.12.003 · Cited by 11
Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?
Mirrakhimov, A. E. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0755-6 · Cited by 11
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 11
Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society
Chattranukulchai, P., Roubsanthisuk, W., Kunanon, S., Kotruchin, P., Satirapoj, B., Wongpraparut, N., Sunthornyothin, S., & Sukonthasarn, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01785-6 · Cited by 11
Treatable Traits-Based Pharmacologic Treatment of Sleep Apnea
Lisik, D., & Zou, D. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.10.002 · Cited by 11
Effect of antihypertensive medications on sleep status in hypertensive patients
Zeng, Z., Yang, Y., Zhang, Y., Wu, X., Chen, W., & Gu, D. (2022) · Sleep and Biological Rhythms · doi:10.1007/s41105-022-00391-8 · Cited by 10
Update on diagnosis and treatment of resistant hypertension.
Pimenta, E. (2011) · Iranian Journal of Kidney Diseases · Cited by 10
Self-citation
Causal Association between Whole-Body Water Mass and Sleep Apnea: A Mendelian Randomization Study
Zhou, T., Xie, J., Wang, X., Gui, C., Wang, Y., Liang, T., Kuang, X., Liao, W., Song, L., & Zhang, X. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202112-1331oc · Cited by 10
Prevalence and associated factors of obstructive sleep apnea in refractory hypertension
Chedier, B., Roderjan, C. N., Cavalcanti, A. H., de Souza, F., & Muxfeldt, E. S. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003144 · Cited by 11
Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients
Schwartz, A. R., Herpel, L. B., Bogan, R., Corser, B. C., Pho, H., & Taranto‐Montemurro, L. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03113-1 · Cited by 9
Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies
Tang, W., Huang, K.-J., Xu, J., Cai, Q., Song, Y.-P., Fan, T.-Q., Zhang, Y., Liu, T., & Li, Y. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01431-x · Cited by 10
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!
Maiolino, G., Azzolini, M., & Rossi, G. P. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00003 · Cited by 9
Managing comorbid cardiovascular disease and sleep apnea with pharmacotherapy
Wolf, J., & Narkiewicz, K. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1476489 · Cited by 9
Renal Denervation vs Pharmacotherapy for Resistant Hypertension: A Meta‐Analysis
Sun, D., Li, C., Li, M., Liu, J., & Wen, S. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12742 · Cited by 10
Primary aldosteronism and obstructive sleep apnea
Nakamura, Y., Kobayashi, H. H., Tanaka, S., Hatanaka, Y., Fuke, Y., Fukuda, N., & Abe, M. (2021) · Medicine · doi:10.1097/md.0000000000025049 · Cited by 9
Sleep Disorders in Chronic Kidney Disease
Brown, L. K., & Unruh, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00036-x · Cited by 10
Resistant Hypertension in Diabetes Mellitus
Bayliss, G. P., Weinrauch, L. A., & D’Elia, J. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0516-y · Cited by 9
Sleep quality in patients with primary aldosteronism
German Conn’s Registry, Hanusch, F. M., Fischer, E., Lang, K., Diederich, S., Endres, S., Allolio, B., Beuschlein, F., Reincke, M., & Quinkler, M. O. (2014) · HORMONES · doi:10.1007/bf03401320 · Cited by 9
Associated factors and hemodynamic characteristics of resistant hypertension in the elderly
Geng, H., Chen, X., Liang, W., & Liu, M. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14640 · Cited by 8
Recent Advancements in the Treatment of Resistant Hypertension
Clark, D., Guichard, J. L., Calhoun, D. A., & Ahmed, M. I. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2519 · Cited by 8
Self-citation
Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study
Hundemer, G. L., Imsirovic, H., Kendzerska, T., Vaidya, A., Leung, A. A. C., Kline, G. A., Goupil, R., Madore, F., Agharazii, M., Knoll, G. A., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad022 · Cited by 8
Uncontrolled hypertension and obstructive sleep apnea: integrated treatment approach
Mikhailova, O. O., Gogiberidze, K. O., Elfimova, E. M., Litvin, A. Y., & Chazova, I. E. (2022) · Systemic Hypertension · doi:10.38109/2075-082x-2022-3-41-47 · Cited by 7
Management of the Hypertensive Child
Ellis, D. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_63 · Cited by 7
Evaluation and Pharmacologic Approach to Patients with Resistant Hypertension
Adams, M., Bellone, J. M., Wright, B. M., & Rutecki, G. W. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2520 · Cited by 6
Obstructive sleep apnea is more severe in men but not women with refractory hypertension compared with controlled resistant hypertension
Thomas, S. J., Siddiqui, M., Judd, E. K., Moore, D., Harding, S. M., Oparil, S., & Calhoun, D. A. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002631 · Cited by 6
Self-citation
Drugs affecting obstructive sleep apnea syndrome
Ostroumova, O. D., Isaev, R. I., Kotovskaya, Y. V., & Tkacheva, O. N. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012009146 · Cited by 6
Obstructive Sleep Apnea and Hypertension: Is Aldosterone Blockade the Optimal Approach to Control Blood Pressure and Improve Oxygenation?
Ikeda, A. K., & Mehra, R. (2026) · Current Hypertension Reports · doi:10.1007/s11906-025-01356-1 · Cited by 5

Authors: Gaddam, K., Pimenta, E., Thomas, S. J., Cofield, S. S., Oparil, S., Harding, S. M., & Calhoun, D. A.
Affiliations: Ochsner Medical Center (US)
The University of Queensland (AU)
University of Alabama at Birmingham (US)
Corresponding author: Calhoun, D A
ORCID: Cofield, S S
Oparil, S
Calhoun, D A
Venue: Journal of Human Hypertension
Publisher: Springer Science and Business Media LLC
Published: 2009-12-17
Volume: 24
Issue: 8
Pages: 532-537
ISSN: 0950-9240 (ISSN-L)
1476-5527
DOI: 10.1038/jhh.2009.96
PMC: PMC2891919
OpenAlex: W2076462334
Cited by: 289
References: 26
Citations by year: 2026: 10 · 2025: 9 · 2024: 10 · 2023: 13 · 2022: 14 · 2021: 12 · 2020: 17 · 2019: 21 · 2018: 19 · 2017: 16 · 2016: 23 · 2015: 25 · 2014: 33 · 2013: 17 · 2012: 22
FWCI: 10.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Journal of Human Hypertension (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01-HL79040, R01HL079040, R01HL075614, P50HL077100, T32HL007457)
National Center for Research Resources (M01RR00032, M01RR000032)
Topics: Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
Keywords: spironolactone, obstructive sleep apnea, resistant hypertension, hyperaldosteronism, mineralocorticoid receptor antagonists, aldosterone, fluid retention, apnea-hypopnea index, plasma renin activity, blood pressure
MeSH terms: Blood Pressure, Diuretics, Drug Resistance, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Pilot Projects, Severity of Illness Index, Spironolactone, Treatment Outcome, Polysomnography, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks